Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs ALHC✓SelectedUSD · ALHCMRNA vs ALHC performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs ALHC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+147.0%
ALHC return
-2.9%
Excess return
+149.9%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioALHCExcessAlpha
1D-2.2%-2.0%-0.2%-2.1%
7D-12.7%-13.5%+0.8%-12.5%
30D-20.7%-24.5%+3.9%-20.5%
3M+46.3%-50.7%+97.0%+47.1%
6M+305.2%-61.8%+367.0%+316.1%
YTD+561.2%-67.7%+629.0%+580.0%
1Y+772.1%-60.4%+832.5%+802.3%
3Y+147.0%-4.8%+151.7%+158.9%
All+147.0%-2.9%+149.9%+158.9%

Cumulative growth

Daily Returns

Daily percentage return beside ALHC.

Daily Out/Under-Performance

Portfolio return minus ALHC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ALHC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded ALHC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling